Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Bio-Techne Corp (TECH) had Normalized Pre-Tax Income of $240.68M for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
$1.22B |
|
$181.86M |
|
$415.97M |
|
$799.07M |
|
$963.15M |
|
$251.89M |
|
$-11.21M |
|
$240.68M |
|
|
Normalized Pre-Tax Income |
$240.68M |
$181.86M |
|
$181.86M |
|
$181.86M |
|
$181.86M |
|
$251.89M |
|
$349.25M |
|
155.96M |
|
157.01M |
|
$1.17 |
|
$1.16 |
|
| Balance Sheet Financials | |
$744.40M |
|
$231.84M |
|
$1.84B |
|
$2.59B |
|
$163.70M |
|
$200.00M |
|
$314.81M |
|
$478.50M |
|
-- |
|
$829.40M |
|
$2.11B |
|
-- |
|
| Cash Flow Statement Financials | |
$292.07M |
|
$-18.19M |
|
$-169.11M |
|
$162.19M |
|
$264.71M |
|
$102.53M |
|
$41.37M |
|
$-49.92M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|